Literature DB >> 27225235

Radiation therapy for primary breast lymphoma in male gynecomastia: a rare case report and review of the literature.

Naoya Ishibashi1, Masaharu Hata2, Takao Mochizuki3, Kogi Ogawa4, Hiroaki Sugiura5, Yoshinori Takekawa6, Toshiya Maebayashi7, Takuya Aizawa7, Masakuni Sakaguchi7, Osamu Abe7.   

Abstract

Primary breast lymphoma is a rare type of non-Hodgkin lymphoma and usually affects women, although a few cases have been reported in men. Chemotherapy and radiation therapy, or a combination of both, are frequently administered for treatment of primary breast lymphoma, as local control by surgical resection is poor. No standard therapy has been established, and the optimal radiation dose and irradiation field for male patients are unknown. The present report describes a 75-year-old man with bilateral cirrhosis-induced gynecomastia who was diagnosed with primary breast lymphoma; specifically, diffuse large B-cell lymphoma. Because of his hepatic dysfunction, he was treated with radiation therapy alone. Radiation therapy was followed by eight cycles of rituximab monotherapy. Clinical response was good, with no signs of relapse. Clinicians may benefit from knowledge regarding effective treatment of primary breast lymphoma in male patients, which has been rarely reported owing to the low incidence of this condition. The outcome in the present case may help to establish effective treatment guidelines in similar cases.

Entities:  

Keywords:  Gynecomastia; Male breast lymphoma; Primary breast lymphoma; Radiation therapy

Mesh:

Substances:

Year:  2016        PMID: 27225235     DOI: 10.1007/s12185-016-2026-y

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  36 in total

1.  Primary Non-Hodgkin's Lymphoma of the Male Breast: A Case Report.

Authors: 
Journal:  Breast Cancer       Date:  1999-01-25       Impact factor: 4.239

2.  Malignant lymphoma of the breast. Immunologic type and association with lymphocytic mastopathy.

Authors:  K Aozasa; M Ohsawa; K Saeki; K Horiuchi; K Kawano; T Taguchi
Journal:  Am J Clin Pathol       Date:  1992-05       Impact factor: 2.493

3.  Primary high-grade B-cell lymphoma of the breast with concurrent IGH-BCL2 and MYC-IGL translocations in an adolescent patient.

Authors:  Xiayuan Liang; Ashley Jones; Roger H Giller; Karen Swisshelm; Loris McGavran; Lynne Meltesen; Billie Carstens; Amy N McGranahan; Edythe A Albano
Journal:  Pediatr Dev Pathol       Date:  2011-04-14

Review 4.  Chimeric antigen receptor modified T cell therapy for B cell malignancies.

Authors:  Cameron J Turtle
Journal:  Int J Hematol       Date:  2013-12-14       Impact factor: 2.490

5.  Occurrence and prognosis of extranodal lymphomas.

Authors:  C Freeman; J W Berg; S J Cutler
Journal:  Cancer       Date:  1972-01       Impact factor: 6.860

6.  Pseudolymphoma of the breast. I. In a study of 8,654 consecutive tylectomies and mastectomies.

Authors:  J J Lin; G J Farha; R J Taylor
Journal:  Cancer       Date:  1980-03-01       Impact factor: 6.860

7.  Postmenopausal unopposed estrogen and estrogen plus progestin use and risk of non-Hodgkin lymphoma in the American Cancer Society Cancer Prevention Study-II Cohort.

Authors:  Lauren R Teras; Alpa V Patel; Janet S Hildebrand; Susan M Gapstur
Journal:  Leuk Lymphoma       Date:  2012-09-14

8.  High circulating oestrone and low testosterone correlate with adverse clinical outcomes in men with advanced liver disease.

Authors:  Marie Sinclair; Paul J Gow; Peter W Angus; Rudolf Hoermann; David J Handelsman; Gary Wittert; Sean Martin; Mathis Grossmann
Journal:  Liver Int       Date:  2016-04-06       Impact factor: 5.828

9.  Primary diffuse large B-cell lymphoma of the breast: prognostic factors and outcomes of a study by the International Extranodal Lymphoma Study Group.

Authors:  G Ryan; G Martinelli; M Kuper-Hommel; R Tsang; G Pruneri; K Yuen; D Roos; A Lennard; L Devizzi; S Crabb; D Hossfeld; G Pratt; M Dell'Olio; S P Choo; R G Bociek; J Radford; S Lade; A M Gianni; E Zucca; F Cavalli; J F Seymour
Journal:  Ann Oncol       Date:  2007-10-11       Impact factor: 32.976

10.  Primary breast lymphoma: patient profile, outcome and prognostic factors. A multicentre Rare Cancer Network study.

Authors:  Wendy Jeanneret-Sozzi; Alphonse Taghian; Ron Epelbaum; Philip Poortmans; Daniel Zwahlen; Beat Amsler; Sylviane Villette; Yazid Belkacémi; Tan Nguyen; Pierre Scalliet; Philippe Maingon; Cristina Gutiérrez; Pauline Gastelblum; Marco Krengli; Rita Abi Raad; Mahmut Ozsahin; René-Olivier Mirimanoff
Journal:  BMC Cancer       Date:  2008-04-01       Impact factor: 4.430

View more
  2 in total

1.  Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography with gallium-67 scintigraphy in the initial clinical staging of diffuse large B-cell lymphoma.

Authors:  Masatoshi Sakurai; Takaaki Toyama; Taku Kikuchi; Jun Kato; Takayuki Shimizu; Yuya Koda; Daiki Karigane; Yusuke Yamane; Ryohei Abe; Rie Yamazaki; Tomonori Nakazato; Tadaki Nakahara; Masahiro Jinzaki; Shinichiro Okamoto; Takehiko Mori
Journal:  Int J Hematol       Date:  2017-10-09       Impact factor: 2.490

2.  Primary breast lymphoma in males: Incidence, demographics, prognostic factors, survival, and comparisons with females.

Authors:  Jie Zhang; Binbin Ma; Hong Ji; Rong Guo
Journal:  Front Surg       Date:  2022-08-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.